WADEBRIDGE & CAMEL ESTUARY PRACTICE
BROOKLYN, WADEBRIDGE
HF003
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, the percentage of patients who are currently treated with an ACE-I or ARB
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| LVD 3 | 2005 | 33 | 43 | 76.7% | |
| LVD 3 | 2006 | 36 | 45 | 80.0% | |
| HF 3 | 2007 | 38 | 44 | 86.4% | |
| HF 3 | 2008 | 39 | 44 | 88.6% | |
| HF 3 | 2009 | 35 | 40 | 87.5% | |
| HF 3 | 2010 | 32 | 37 | 86.5% | |
| HF 3 | 2011 | 32 | 37 | 86.5% | |
| HF 3 | 2012 | 29 | 34 | 85.3% | |
| HF 3 | 2013 | 34 | 40 | 85.0% | |
| HF003 | 2014 | 20 | 20 | 100.0% | |
| HF003 | 2015 | 26 | 26 | 100.0% | |
| HF003 | 2016 | 23 | 23 | 100.0% | |
| HF003 | 2017 | 25 | 25 | 100.0% | |
| HF003 | 2018 | 26 | 26 | 100.0% | |
| HF003 | 2019 | 38 | 38 | 100.0% | |
| HF003 | 2020 | 36 | 37 | 97.3% | |
| HF003 | 2021 | 48 | 56 | 85.7% | |
| HF003 | 2022 | 99 | 107 | 92.5% | |
| HF003 | 2023 | 125 | 140 | 89.3% |
